EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions

Katrin Bratl, Claire Butters iD, Kate Webb iD, Georgia Schäfer iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27031275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Katrin Bratl und 3 weiteren Autor:innen. Beteiligte Einrichtung: International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town 7925, South Africa. Hauptthemen laut MEDLINE: COVID-19, Inflammation, Herpesviridae Infections, Epstein-Barr Virus Infections. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European & Developing Countries Clinical Trials Partnership, National Research Foundation, South African Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi’s Sarcoma-associated herpesvirus (KSHV) and Epstein–Barr virus (EBV) are oncogenic gammaherpesviruses with high prevalence in sub-Saharan Africa. Both viruses are typically acquired during childhood, establishing lifelong latency. While viral reactivation into the lytic cycle has been mainly studied in adult HIV-infected populations—and more recently in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection—the dynamics of KSHV and EBV infection in children remain poorly understood. Here, we characterize pediatric patients (n = 175; median age 4.6 years; IQR 2.0–8.3) presenting with inflammatory conditions during the COVID-19 pandemic in South Africa (from July 2020 to February 2024). Including a healthy, non-inflammatory control group, we found widespread exposure to SARS-CoV-2 (70.9% seropositivity), with 72.6% of the children being seropositive for EBV and 19.4% for KSHV. There were no significant differences in seroprevalence between children with inflammatory conditions and healthy controls for any of these viruses, although SARS-CoV-2 antibody titers were significantly higher in the inflammatory group, while EBV immune responses were lower in children presenting with inflammation. Among the KSHV-seropositive children, no active viremia was detected (as determined by the absence of viral DNA in the peripheral blood). In contrast, 34.4% of EBV-seropositive children had detectable EBV viral load, with a modestly higher proportion in the inflammatory group. However, EBV viral load levels were comparable between children diagnosed with Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease (KD), and other inflammatory conditions. Logistic regression analyses revealed that increasing age was significantly associated with higher risk of SARS-CoV-2 and EBV seropositivity, but not KSHV. Notably, the risk of EBV DNA detection in the peripheral blood decreased with age. In summary, this study suggests effective immunological control of gammaherpesvirus infections in HIV-negative paediatric patients, even in the presence of inflammatory conditions that might otherwise trigger viral reactivation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19InflammationHerpesviridae InfectionsEpstein-Barr Virus InfectionsHumansMaleFemaleSouth AfricaHerpesvirus 8, HumanChildSeroepidemiologic StudiesChild, PreschoolHerpesvirus 4, HumanSARS-CoV-2Antibodies, ViralCoinfection

Stichwörter der Autor:innen

COVID-19Epstein–Barr virus (EBV or HHV-4)Kaposi’s sarcoma-associated herpesvirus (KSHV or HHV-8)Kawasaki disease (KD)Sub-Saharan Africamultisystem inflammatory syndrome in children (MIS-C)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town 7925, South Africa.
  • Institute of Infectious Disease and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
  • Division of Medical Biochemistry and Structural Biology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
  • Division of Rheumatology, Department of Paediatrics and Child Health, University of Cape Town, Cape Town 7700, South Africa.
  • Francis Crick Institute, London NW1 1AT, UK.
  • Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town 7925, South Africa.

ORCID-Profile: Claire Butters, Kate Webb, Georgia Schäfer

Förderung

  • European & Developing Countries Clinical Trials Partnership
  • National Research Foundation
  • South African Medical Research Council
  • Poliomyelitis Research Foundation
  • Medical Research Council
  • Wellcome Trust
  • European Union
  • South African National Research Foundation

Zitieren

APA

Bratl, K., Butters, C., Webb, K., & Schäfer, G. (2026). Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031275

Vancouver

Bratl K, Butters C, Webb K, Schäfer G. Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031275

BibTeX
@article{Bratl2026,
  author = {Bratl, Katrin and Butters, Claire and Webb, Kate and Schäfer, Georgia},
  title = {Assessing Seroprevalence and Infection Dynamics of Oncogenic Gammaherpesviruses in South African Paediatric Patients Presenting with Inflammatory Conditions},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27031275}
}
Kostenlos starten →